Kazuhiro Uesugi

A phase II study of modified FOLFIRINOX for chemotherapy-naïve patients with metastatic pancreatic cancer

Masato Ozaka, Hiroshi Ishii, Tosiya Sato et al. · Cancer Chemotherapy and Pharmacology · 2018 · 163 citations

Medicine, Oncology, Pharmacology +14

Phase II clinical trial of peptide cocktail therapy for patients with advanced pancreatic cancer: <scp>VENUS</scp> ‐ <scp>PC</scp> study

Nobuaki Suzuki, Shoichi Hazama, Haruo Iguchi et al. · Cancer Science · 2016 · 65 citations · Full text

Pharmacy, Immunology, Oncology +16

Amino acid imbalance in patients with chronic liver diseases

Kojiro Michitaka, Atsushi Hiraoka, Misaki Kume et al. · Hepatology Research · 2010 · 55 citations

Medicine, Pathobiology, Clinical Biochemistry +16

Predictive biomarkers for the efficacy of peptide vaccine treatment: based on the results of a phase II study on advanced pancreatic cancer

Yoshitaro Shindo, Shoichi Hazama, Nobuaki Suzuki et al. · Journal of Experimental & Clinical Cancer Research · 2017 · 35 citations · Full text

Medicine, Immunology, Oncology +17

FOLFIRINOX for locally advanced pancreatic cancer: Results and prognostic factors of subset analysis from a nation-wide multicenter observational study in Japan

Ippei Matsumoto, Keiko Kamei, Katsuhiro Omae et al. · Pancreatology · 2019 · 33 citations

Medicine, Oncology, Surgery +13